Logos Global Management LP

CIK 1792126 · last filed 2021-06-22

Logos Global Management LP is a corporate insider who has filed 3 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for VERV, was dated Jun 22, 2021. Across all open-market trades the lifetime net is +$22.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $34.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$34.71M

Companies

3

Total Filings

3

Lifetime Open-Market Net

$22.33M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Verve Therapeutics, Inc. (VERV) Delisted	10%+ Owner	813,265	$11.13	$9.05M	$7.03M	1	2021-06-22
Eledon Pharmaceuticals, Inc. (NVUS) Delisted	10%+ Owner	150,000	—	—	$2.00M	1	2020-11-06
DYN	10%+ Owner	1,504,392	$23.07	$34.71M	$13.30M	1	2020-09-23

Recent Filings

3 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2021-06-22	Verve Therapeutics, Inc. (VERV) Delisted	Mixed	+813,265	$7.03M	EDGAR
2020-11-06	Eledon Pharmaceuticals, Inc. (NVUS) Delisted	Mixed	+79,071	$2.00M	EDGAR
2020-09-23	DYN	Mixed	+1,504,392	$13.30M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.